Building Biotech Businesses - - BioPharm International

ADVERTISEMENT

Building Biotech Businesses

BioPharm International


He continued, "The biotechnology industry is fast-moving, international, and highly dynamic. The Enterprise Ireland strategy is likewise dynamic, in line with the needs of biotech business developing in a fast-moving business and scientific environment."

Enterprise Ireland's Building Biotech Businesses strategy is clearly fulfilling its mission of helping grow and develop Ireland's entrepreneurial-led biotechnology and life sciences industries. Building Biotech Businesses will continue to encourage creation of new commercially focused biotech companies in Ireland, to nurture early-stage biotech companies, and to target foreign biotech entrepreneurs and early-stage companies with potential to locate in Ireland. It will also continue to fast-track biotech company development, and to encourage private-sector seed and venture capital in Ireland. The EI biotech team is now in place and is integrating its resources to deliver on the goals of this strategy — goals which, together with other progressive EI initiatives, will all play key roles in biotech sector development in Ireland now, and in years to come.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

First Biosimilar Application Kicks Off Legal Battle
October 31, 2014
FDA Approves Pfizer's Trumenba for the Prevention of Meningitis B
October 30, 2014
EMA: Extrapolation Across Indications for Biosimilars a Possibility
October 30, 2014
Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Amgen, Sanofi, and Ono Pharmaceuticals Partner with Universities on Transmembrane Protein Research
October 28, 2014
Author Guidelines
Source: BioPharm International,
Click here